CD4+ T cells most commonly associated with anti-tumor responses include Th1, Th9, and Th17 cells, which drive cell-mediated responses [46], while Th2 cells support the humoral arm of the adaptive immune response considered less effective at containing tumors [47]. The gene discussed is CD4; the disease is neoplasm.